Medical Ozone Generator for Cosmetology Medozons BM-02

1. Purpose

Medical ozone generator Medozons-BM-02 with a built-in low-flow multi-injectory unit is a modification of serial ozone machine MEDOZONS-BM. This modification allows performing both the “traditional” and new methods of ozone therapy, in particular subcutaneous injections of an ozone/oxygen gas ixture (in further the O2/O3 mixture) at considerable volumes. This method is used in the treatment of large body surfaces damaged by local lipodystrophy. Thanks to its high efficiency this method is also alled the multi-injectory “non-surgical” liposuction.

2. Construction Features

The main difference of the modified ozone machine from the serial one is that through a built-in low-flow unit it can deliver the O2/O3 mixture at a low flow-rate from 5 to 10 ml/min. That allows introducing the
O2/O3 mixture into a problem area directly from ozone generator (by using a multi-injector for 5 needles, he flow-rate through each needle is 1-2 ml/min) thereby creating comfortable conditions for the patient.


Fig. 1. Medical ozone generator MEDOZONS BM-02 with a builtin low-flow unit and multi-injector.


Fig. 1. demonstrates operation schema of medical ozone generator MEDOZONS-BM-02 with a built-in low-flow unit and multi-injector. Excess of the O2/O3 mixture is removed to a destructor. For this treatment use the right-port jet of ozone generator, and the left-port jet must be closed with a screw cap. 
The multi-injector is connected with the distributing tubes from the accessories set (order-No. 103\01), the distributing tubes are fitted with thin needles “Luer” G30 0,3x13 (order-No. 101\02).

3. Treatment Performance
3.1. Perform a preparatory massage of the problem area. Treat the problem area with 70% spirit.
3.2. Press the button “START”, remove protective caps from the sterile needles, apply the needles intracutaneously at an angle of 30o on a perimeter of the problem area at a distance of 7-10 cm from each other (Fig. 3). Within first 3-5 min of procedure the patient can feel slight expansion of tissues at the places f injections.
3.3. After 3-5 min at the place of injections it comes to slight hyperemia and hilliness of skin surface that can intensify to fusion of separate areas.


Fig. 2. Technique of introduction of the O2/O3 mixture into the area of thigh: 1 - preparatory stage; 2 - performance of treatment; 3 - problem area after the treatment.


3.4. The introduction of the O2/O3 mixture should be performed under strict control of medical personnel, and in case of fusion of hyperemia areas and/or hilliness of skin surface it is necessary to carry the needles on the areas without hyperemia symptoms.
3.5. The procedure lasts for 10-15 min, within this time 100-150 ml of the O2/O3 mixture is introduced (4-7% of body surface is covered by treatment). After the procedure perform manual or apparative vacuum massage of the problem area with ozonized olive oil for equal istribution of gas mixture through subcutaneous fatty tissue.

3.6. Within one procedure it is possible to introduce the O2/O3 mixture into several problem areas through migration of needles (for example, from the right thigh to the left one), while the total time of procedure and volume of the O2/O3 mixture introduced emains stable.
3.7. After the procedure it can come to crepitation (crunch) not only at the places of direct introduction of the O2/O3 mixture, but also at remote areas that is not considered as a complication, but a successful result of treatment. Crepitation can last up to 2 ays.
3.8. Advantages of this method in comparison with a syringe method are the following:

  • An increase in clinical efficiency by 15-30%;

  • A decrease in traumatology of skin covers through a decrease in the number of injections by 6-10 times;

  • More equal distribution of the O2/O3 mixture at the area of injections;

  • No bruises and hematomas at the places of injections (Fig. 3-1).

4. Contraindications / Limitations
4.1 Contraindications for treatment:

  • Disturbances of blood coagulation;

  • Thyroid diseases;

  • Acute inflammatory diseases

4.2 To ensure no adverse effects during the treatment the following principles should be strictly followed:

  • in case of local ozone treatments do not use any other medicament at the same place;

  • at the beginning of a treatment course perform a trial procedure of ozone therapy in order to see the patients reaction.

4.3 Ozone therapy can be used in combination with any other pharmaceuticals (except anticoagulants) and with any other physical therapies not to be performed at the same time. The main reasons for rare side effects due to ozone therapy are the improper technique of administration and incorrectly chosen dosage.
4.4 Ozone treatments can be performed both by physician and medical nurse, but first procedure must be performed under control of physician. The procedure should be immediately stopped if the patients condition
gets anyway worse.
4.5 For treatment use only special equipment and accessories.
4.6 The treatment room should be equipped with plenum-exhaust ventilation, conditioner or window ventilator to ensure no inhalative exposure of ozone to the patient and medical personnel


Technical Data & Features


Technical Data & Features Value/availability
Principle of ozone generation: electric synthesis of ozone from oxygen in unbalanced low-temperature plasma of impulse barrier discharge of microsecond's duration by automatic pre-ionization - independently from the oxygen flow-rate or voltage!!!;
Ozone production stabilization time: max. 3 min to reach the adjusted ozone concentration
Thermoregulation: automatic

Range of delivered ozone concentrations:

50 … 10 000 mcg/L at a step of 1 mcg/L (9950 different ozone concentrations)

Accuracy in maintaining the chosen ozone concentration:

± 5%;
Ozone/oxygen flow rate: 0,25 L/min, 0,5 L/min, 1,0 L/min (automatically maintained)
Accuracy in maintaining the chosen ozone/oxygen flow-rate: ± 5%;
Treatment time range: 0 … 60 min at a step of 1 min;
A built-in count-down timer: available
A total operation time calculator: available
A built-in low-flow multi-injectory valve: available in MEDOZONS-BM-02 only
Durability of the ozonization chamber before scheduled prophylactic service: 2000 hrs of continuous operation (approx. 7000 infusions of ozonated saline or 40000 ozone injections)
Operating system: completely automated operating system based on the built-in microprocessor Intel; automatically blocking in case of any wrong actions of the user by indicating an error index on the display
Ozone/oxygen outlets: 2 continuous-flow ozone outlets in the side niches + 1 syringe filling port "DISPENSER" on the front panel
Safety features: equipped with the systems of inlet oxygen extra purification and prevention of solution leakage into the unit as well as with a remote destructor to ensure no inhalative exposure of ozone to the patient and medical personnel
Quality of ozone/oxygen gas mixtures delivered: no micro-contaminants in accordance with mass-spectrometry evidence
External option: can be connected to the PC via RS-232 cable
Required oxygen pressure: 0,3 to 1,5 bar (atm)
Electric data: 220+22V; 50Hz; 30 W (110-120V/60Hz as option), safety class "I", type "B"
Dimensions (H x W x D): 180 x 335 x 425mm
Weight: max. 8,5kg
Life-span: not less than 5000 hrs of continuous operation (approx. 10 years)
Required oxygen purity: 99,9% and higher
Warranty: 2 years
Compliance: approved by the Russian Ministry of Health, Russian Certification Institute according to GOST standards as well as Certification Notified Body TUEV Austria according to European standards (CE)
Customization: comes with Standard Accessory Packages (AP) according to medical specialty: Basic AP, Universal AP, Obstetric-Gynecological AP-1 (mini) and AP-2 (maxi), Surgical AP, Dermatovenereological AP, Cosmetological AP-1 and AP-2
Fields of medical application: internal medicine, surgery, urology, obstetrics & gynecology, neuropathology, infectious diseases, combustiology, dermatovenereology, ophthalmology, dentistry, cosmetology, traumatology, intensive care etc.